Nora Ku

4.5k total citations
24 papers, 584 citations indexed

About

Nora Ku is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Nora Ku has authored 24 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Nora Ku's work include Chronic Lymphocytic Leukemia Research (6 papers), CAR-T cell therapy research (4 papers) and Glioma Diagnosis and Treatment (4 papers). Nora Ku is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), CAR-T cell therapy research (4 papers) and Glioma Diagnosis and Treatment (4 papers). Nora Ku collaborates with scholars based in United States, Spain and United Kingdom. Nora Ku's co-authors include Janis V. Giorgi, Richard E. Champlin, Stephen A. Ferrara, Andrew Saxon, Jan Storek, Alexander Drilon, Gary J. Schiller, Michael T. Selch, James Gajewski and Thomas A. Reichert and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Nora Ku

22 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nora Ku United States	11	250	202	168	128	124	24	584
VM Santana United States	9	240 1.0×	101 0.5×	310 1.8×	185 1.4×	58 0.5×	11	674
J. Graham Sharp United States	12	255 1.0×	113 0.6×	250 1.5×	181 1.4×	40 0.3×	26	633
Hideaki Mizoguchi Japan	14	274 1.1×	313 1.5×	174 1.0×	194 1.5×	40 0.3×	30	703
Ugo Consoli Italy	17	257 1.0×	239 1.2×	395 2.4×	367 2.9×	31 0.3×	36	863
M. Brandely France	14	164 0.7×	326 1.6×	262 1.6×	119 0.9×	138 1.1×	36	760
Marianne Rissler Sweden	15	565 2.3×	219 1.1×	212 1.3×	322 2.5×	47 0.4×	32	1.0k
Sujiang Zhang China	13	368 1.5×	98 0.5×	149 0.9×	329 2.6×	45 0.4×	62	710
Yasunori Nakagawa Japan	13	232 0.9×	250 1.2×	255 1.5×	278 2.2×	32 0.3×	37	688
Esohe Idusogie United States	6	226 0.9×	275 1.4×	79 0.5×	359 2.8×	37 0.3×	7	770
Jochen Casper Germany	13	313 1.3×	75 0.4×	145 0.9×	241 1.9×	86 0.7×	39	701

Countries citing papers authored by Nora Ku

Since Specialization

Citations

This map shows the geographic impact of Nora Ku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Ku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Ku more than expected).

Fields of papers citing papers by Nora Ku

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Ku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Ku. The network helps show where Nora Ku may publish in the future.

Co-authorship network of co-authors of Nora Ku

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Ku. A scholar is included among the top collaborators of Nora Ku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Ku. Nora Ku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dumbrava, Ecaterina E., Christopher T. Chen, Gregory M. Coté, et al.. (2023). Abstract B034: A phase 2 basket study of the oral MDM2 inhibitor milademetan for MDM2-amplified advanced solid tumors (MANTRA-2). Molecular Cancer Therapeutics. 22(12_Supplement). B034–B034. 1 indexed citations

Roeker, Lindsey E., Anthony R. Mato, Jennifer R. Brown, et al.. (2022). Abstract CT138: Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in combination with venetoclax ± rituximab in relapsed/refractory chronic lymphocytic leukemia: Results from the BRUIN phase 1b study. Cancer Research. 82(12_Supplement). CT138–CT138. 1 indexed citations

Alencar, Alvaro J., Lindsey E. Roeker, Marc Hoffmann, et al.. (2021). A First-in-Human Phase 1 Study of Oral LOXO-338, a Selective BCL2 Inhibitor, in Patients with Advanced Hematologic Malignancies (Trial in Progress). Blood. 138(Supplement 1). 2424–2424. 6 indexed citations

Nardi, Valentina, Nora Ku, Matthew J. Frigault, et al.. (2020). Clinical response to larotrectinib in adult Philadelphia chromosome–like ALL with cryptic ETV6-NTRK3 rearrangement. Blood Advances. 4(1). 106–111. 22 indexed citations

Rosen, Ezra Y., Alison M. Schram, Robert J. Young, et al.. (2019). Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid Tumors. JCO Precision Oncology. 3(3). 1–5. 21 indexed citations

Hong, David S., Shivaani Kummar, Anna F. Farago, et al.. (2019). Larotrectinib efficacy and safety in adult TRK fusion cancer patients.. Journal of Clinical Oncology. 37(15_suppl). 3122–3122. 5 indexed citations

Drilon, Alexander, Steven G. DuBois, Anna F. Farago, et al.. (2019). Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors.. Journal of Clinical Oncology. 37(15_suppl). 2006–2006. 55 indexed citations

Kato, Shunsuke, Junya Fujimura, Shigeo Yamaguchi, et al.. (2019). [A Case of Pediatric Soft Tissue Sarcoma with LMNA-NTRK1 Gene Fusion Treated with Larotrectinib under Single Patient Expanded Access System].. PubMed. 46(10). 1595–1597. 3 indexed citations

Mato, Anthony R., Ian W. Flinn, John M. Pagel, et al.. (2019). Results from a First-in-Human, Proof-of-Concept Phase 1 Trial in Pretreated B-Cell Malignancies for Loxo-305, a Next-Generation, Highly Selective, Non-Covalent BTK Inhibitor. Blood. 134(Supplement_1). 501–501. 22 indexed citations

10.

Schram, Alison M., Philip Jonsson, Alexander Drilon, et al.. (2018). Genomic Heterogeneity Underlies Mixed Response to Tropomyosin Receptor Kinase Inhibition in Recurrent Glioma. JCO Precision Oncology. 2(2). 1–6. 3 indexed citations

11.

Ilouze, Maya, Simon Wein, Victoria Neiman, et al.. (2017). Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 Fusion. Clinical Breast Cancer. 18(3). e267–e270. 18 indexed citations

12.

Drilon, Alexander, et al.. (2016). A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Adult Subjects with NTRK Fusion-Positive Tumors.. Journal of Clinical Oncology. 34(15_suppl). TPS2599–TPS2599. 3 indexed citations

13.

Tusé, Daniel, Nora Ku, Maurizio Bendandi, et al.. (2015). Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma. BioMed Research International. 2015. 1–15. 54 indexed citations

14.

Collins, Robert H., Hagop M. Kantarjian, Mark J. Levis, et al.. (2014). Clinical activity of Crenolanib in patients with D835 mutant FLT3-positive relapsed/refractory acute myeloid leukemia (AML).. Journal of Clinical Oncology. 32(15_suppl). 7027–7027. 22 indexed citations

15.

Matro, Jennifer M., Jian Yu, Michael C. Heinrich, et al.. (2014). Correlation of PET/CT and CT RECIST response in GIST patients with PDGFRA D842V gene mutations treated with crenolanib.. Journal of Clinical Oncology. 32(15_suppl). 10546–10546. 3 indexed citations

16.

Bendandi, Maurizio, Carlos Becerra, Joseph A. Kuhn, et al.. (2011). Idiotypic Vaccination of Patients with Relapsed Follicular Lymphoma Using a Novel Vaccine Formulation Including a Tobacco Plant-Produced Tumor Specific Idiotype. Blood. 118(21). 1649–1649. 1 indexed citations

17.

Bendandi, Maurizio, Carlos Becerra, Joseph A. Kuhn, et al.. (2011). Single Agent Bendamustine Is An Effective Pre-Vaccine Treatment for Patients with Relapsed Follicular Lymphoma Undergoing Idiotypic Vaccination. Blood. 118(21). 2691–2691. 1 indexed citations

18.

Nimer, Stephen D., Janis V. Giorgi, James Gajewski, et al.. (1994). SELECTIVE DEPLETION OF CD8+ CELLS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION A RANDOMIZED CONTROLLED TRIAL. Transplantation. 57(1). 82–87. 125 indexed citations

19.

Storek, Jan, Stephen A. Ferrara, Nora Ku, et al.. (1993). B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny?. PubMed. 12(4). 387–98. 117 indexed citations

20.

Ku, Nora, et al.. (1984). Mammotroph Autoregulation: Uptake of Secreted Prolactin and Inhibition of Secretion*. Endocrinology. 114(6). 2060–2067. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact